. 2019; 36(4): 230-237 | DOI: 10.4274/tjh.galenos.2019.2018.0307 | |||
Refrakter Kronik İmmün Trombositopeni Tedavisinde Eltrombopagın Etkinliğine İlişkin Çok Merkezli Bir Çalışma: Gerçek Yaşam DeneyimiDemet Çekdemir1, Serkan Güvenç2, Füsun Özdemirkıran3, Ali Eser4, Tayfur Toptaş4, Vildan Özkocaman5, Handan Haydaroğlu Şahin6, Esra Ermiş Turak7, Ramazan Esen8, Melda Cömert9, Sevil Sadri10, Müzeyyen Aslaner11, Bahar Uncu Ulu12, Abdullah Karakuş13, Derya Selim Batut14, İnci Alacacıoğlu15, Demet Aydın, Atakan Tekinalp, Sinem Namdaroğlu, Funda Ceran1Anadolu Medical Center, Bone Marrow Transplantation Center, Department of Hematology, Kocaeli, Turkey2Yeni Yüzyıl University Gaziosmanpaşa Hospital, Department of Hematology, İstanbul, Turkey 3İzmir Atatürk Training and Research Hospital, Clinic of Hematology, İzmir, Turkey 4Marmara University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey 5Uludağ University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Bursa, Turkey 6Gaziantep University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Gaziantep, Turkey 7Erciyes University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Kayseri, Turkey 8Van Yüzüncü Yıl University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Van, Turkey 9İnönü University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Malatya, Turkey 10İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey 11Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Zonguldak, Turkey 12Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Clinic of Hematology, Ankara, Turkey 13Dicle University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Diyarbakır, Turkey 14Karadeniz Teknik University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Trabzon, Turkey 15Dokuz Eylül University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İzmir, Turkey Amaç: Bu çalışmanın amacı kronik immün trombositopeni (ITP) hastalarında bir oral trombopoietin reseptör agonisti olan eltrombopagın etkinlik ve güvenirliliğini değerlendirmektir. A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life ExperienceDemet Çekdemir1, Serkan Güvenç2, Füsun Özdemirkıran3, Ali Eser4, Tayfur Toptaş4, Vildan Özkocaman5, Handan Haydaroğlu Şahin6, Esra Ermiş Turak7, Ramazan Esen8, Melda Cömert9, Sevil Sadri10, Müzeyyen Aslaner11, Bahar Uncu Ulu12, Abdullah Karakuş13, Derya Selim Batut14, İnci Alacacıoğlu15, Demet Aydın, Atakan Tekinalp, Sinem Namdaroğlu, Funda Ceran1Anadolu Medical Center, Bone Marrow Transplantation Center, Department of Hematology, Kocaeli, Turkey2Yeni Yüzyıl University Gaziosmanpaşa Hospital, Department of Hematology, İstanbul, Turkey 3İzmir Atatürk Training and Research Hospital, Clinic of Hematology, İzmir, Turkey 4Marmara University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey 5Uludağ University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Bursa, Turkey 6Gaziantep University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Gaziantep, Turkey 7Erciyes University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Kayseri, Turkey 8Van Yüzüncü Yıl University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Van, Turkey 9İnönü University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Malatya, Turkey 10İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey 11Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Zonguldak, Turkey 12Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Clinic of Hematology, Ankara, Turkey 13Dicle University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Diyarbakır, Turkey 14Karadeniz Teknik University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Trabzon, Turkey 15Dokuz Eylül University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İzmir, Turkey Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran, Ali Eser, Tayfur Toptaş, Vildan Özkocaman, Handan Haydaroğlu Şahin, Esra Ermiş Turak, Ramazan Esen, Melda Cömert, Sevil Sadri, Müzeyyen Aslaner, Bahar Uncu Ulu, Abdullah Karakuş, Derya Selim Batut, İnci Alacacıoğlu, Demet Aydın, Atakan Tekinalp, Sinem Namdaroğlu, Funda Ceran. A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience. . 2019; 36(4): 230-237 Sorumlu Yazar: Demet Çekdemir, Türkiye |
|